Inicio > GARCIA ORTEGA, MARIA DEL PILAR

GARCIA ORTEGA, MARIA DEL PILAR

PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Medicina, Dermatología y Toxicología
 
mariapilar.garcia@uva.es
0

Índice H en Scopus: 16
 
Enlazar esta página

[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56695]], camposKey:2210-7703 2020-01-01 Bullous pemphigoid associated with the use of dipeptidil peptidase-4 inhibitors: analysis from studies based on pharmacovigilance databases713720, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56817]], camposKey:0214-3429 2019-01-01 Guillain-Barré syndrome and influenza vaccines: current evidence. Síndrome de Guillain-Barré y vacuna antigripal: evidencia actual288295, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41161]], camposKey:0165-1781 2018-01-01 Antipsychotics and cardiovascular risk: A case/non-case study341347, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56757]], camposKey:0114-5916 2017-01-01 Atypical Fracture of the Sternum After Long-Term Alendronate Plus Cholecalciferol Treatment: A Case Report00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39773]], camposKey:0268-1315 2017-01-01 Risk excess of mortality and use of antipsychotics: a case-noncase study15, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37]], camposKey:0033-3506 2016-01-01 Impact of regulatory measures on antipsychotics drug consumption in Castilla y Leon, Spain113119, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3371]], camposKey:1053-8569 2015-01-01 Emergency contraceptive pill safety profile. Comparison of the results of a follow-up study to those coming from spontaneous reporting9397, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40045]], camposKey:0114-5916 2013-01-01 Adverse Events Associated with Emergency Contraceptive: Comparing the Results of a Follow Up Study with Those Coming from Spontaneous Reporting874874, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39]], camposKey:0031-6970 2013-01-01 Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study559564, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9199]], camposKey:1742-7835 2013-01-01 Weight Gain and Antipsychotics. A Case/non-case approach in vigibase88, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40046]], camposKey:1053-8569 2012-01-01 Dementia Mortality Rates and Cholinesterase Inhibitors Consumption in Castilla y Leon (Spain). An Ecologic Study7474, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30]], camposKey:1742-7835 2012-01-01 MUSCULOSKELETAL SYMPTOMS ASSOCIATED WITH BISPHOSPHONATES. A RETROSPECTIVE FOLLOW-UP STUDY WITH INFORMATION FROM THE HEALTH IMPROVEMENT NETWORK (THIN)3536, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3372]], camposKey:1053-8569 2012-01-01 Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): Changes in the consumption pattern following the introduction of extended release methylphenidate435441, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38]], camposKey:0264-410X 2011-01-01 Adverse events associated with pandemic influenza vaccines: Comparison of the results of a follow-up study with those coming from spontaneous reporting519522, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=33]], camposKey:1742-7835 2011-01-01 Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study3940, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3384]], camposKey:0031-6970 2004-01-01 Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study439444, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=18838]], camposKey:0212-6567 2002-01-01 Toxicodermia asociada a alendronato6161, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59317]], camposKey:0025-7753 2001-01-01 Cholestatic hepatitis by ticlopidin Hepatitis colestásica por ticlopidina.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=18837]], camposKey:0025-7753 2001-01-01 Chronic urticaria at the down of the millennium617618][][][Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=105018],camposKey=Lo fundamental en alergia 1 1986-01-01 }][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145635367]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4046b923][][][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413366], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41315d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4131d9]][][][][]

AYUDA A LA INVESTIGACIÓN

PUBLICACIONES

Artículos de revista (19)

Molina-Guarneros J.A.; Sainz-Gil M.; Sanz-Fadrique R.; Garcia P.; Rodriguez-Jimenez P.; Navarro-Garcia E.; Martin L.H. Bullous pemphigoid associated with the use of dipeptidil peptidase-4 inhibitors: analysis from studies based on pharmacovigilance databases. International Journal of Clinical Pharmacy 2020; 42(2): 713-72.
Enlace a la publicación
Ver Todos

Libros (1)

Garcia Ortega, P. Lo fundamental en alergia 1986.
Ver Todos
 

AYUDA A LA INVESTIGACIÓN

Proyectos (3)

AUMENTO DE PESO ASOCIADO AL USO DE ANTIPSICÓTICOS: INTERACCIONES ENTRE FACTORES GENÉTICOS Y AMBIENTALES. ESTUDIO DE COHORTES. CARVAJAL GARCIA PANDO, ALFONSO (IP); MARTIN ARIAS, LUIS HERMENEGILDO (IP); TRECEÑO LOBATO, CARLOS; FIERRO LORENZO, MARIA INMACULAD; URIBE LADRON DE CEGAMA, FERNANDO MANUEL DE; REDONDO DEL RIO, MARIA PAZ; GARCIA ORTEGA, MARIA DEL PILAR; JIMENO BULNES, NATALIA; VELASCO GONZALEZ, VERONICA; MATEO SILLERAS, BEATRIZ DE. VA315U14. UNIVERSIDAD DE VALLADOLID, JUNTA DE CASTILLA Y LEÓN -CONSEJERÍA DE EDUCACIÓN 2014-2017
Ver Todos
 

OTROS

Tesis doctorales (1)

RODRIGUEZ PAREDES, JUAN OSTEONECROSIS POR FÁRMACOS: PERFIL BENEFICIO / RIESGO EN EL USO DE BISFOSFONATOS. Universidad de Valladolid; 2012.
Texto completo en acceso abierto  
Ver Todos

Congresos (1)

XII Jornadas de Farmacovigilancia, Santa Cruz de Tenerife ( ESPAÑA ) 09/05/2013 - 10/05/2013
(Comunicación). Sainz Gil, María; Otero López, MJ; Pérez López, R; Salado Valdivieso, I; Treceño Lobato, C; García Ortega, P; Martín Arias, LH; Carvajal García-Pando, A. Metotrexato y errores graves de medicación. Un problema sin resolver
Ver Todos
Cargando información ...
Universidad de Valladolid - Copyright Universidad de Valladolid - Todos los derechos reservados